General Announcement::Regulation 30 of SEBI (LODR) Regulations, 2015 CRISIL Ratings

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
23-Dec-2021 21:36:04
Status
New
Announcement Sub Title
Regulation 30 of SEBI (LODR) Regulations, 2015 CRISIL Ratings
Announcement Reference
SG211223OTHRIEDS
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
23/12/2021 00:00:00
Description (Please provide a detailed description of the event in the box below)
With reference to the subject mentioned above, we have to inform you that, CRISIL Ratings has upgraded the credit rating as enclosed

Attachments

SGX_Intimation.pdf
Total size =298K